United States · Series B startup

Who invested in Rempex Pharmaceuticals

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$68Mraised across 1 round since 2011, from 1 source

Latest round
Series B, $68MNov 2011
Investors
5
See who backed them

The rounds

  1. Nov 2011

The exit

ExitBuyerPriceWhen
AcquiredThe Medicines Company$464MDec 2013

From historical deal records. Wrong? Tell us.

Everyone who backed them

OrbiMedPrivate equity1round
SV Life SciencesVC firm1round
Frazier Healthcare PartnersPrivate equity1round
Vivo VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rempex Pharmaceuticals

Who invested in Rempex Pharmaceuticals?

Rempex Pharmaceuticals's investors include OrbiMed, Adams Street Partners, SV Life Sciences, Frazier Healthcare Partners and Vivo Ventures.

How much has Rempex Pharmaceuticals raised?

Rempex Pharmaceuticals has raised $68M across 1 round since 2011.

When did Rempex Pharmaceuticals last raise?

Rempex Pharmaceuticals's most recent round was a Series B of $68M in Nov 2011.

What was Rempex Pharmaceuticals's biggest round?

Its most recent round, $68M in Nov 2011, is also its largest on record.

Who backed Rempex Pharmaceuticals first?

Rempex Pharmaceuticals's first round on record, in Nov 2011, was backed by OrbiMed, Adams Street Partners and SV Life Sciences and 2 others.

What stage is Rempex Pharmaceuticals at?

Rempex Pharmaceuticals's latest named round is a Series B, in Nov 2011.

Where is Rempex Pharmaceuticals based?

Rempex Pharmaceuticals is based in the United States.

Companies like Rempex Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.